Health Condition 1: J020- Streptococcal pharyngitis
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Sun Pharmaceutical Industries Limited (SPIL)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients aged more than or equal to 18 years of either gender 2. Patients with signs and symptoms of pharyngitis suggestive of bacteriological etiology, alone or in combination (fever, sore throat, throat pain/difficulty in swallowing, inflammation of tonsils) at the initiation of treatment 3. Patients prescribed with oral cephalexin and clavulanic acid combination or other commonly prescribed antibiotics (Amoxicillin + clavulanic acid or Azithromycin) for the management of pharyngitis
Exclusion criteria
Exclusion criteria: 1. Patients with incomplete medical records with respect to the required study parameters 2. Patients requiring hospitalization or parenteral antibiotic treatment 3. Patients with history of allergy or contraindications to study medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients achieving clinical cure from baseline till 10 days from treatment initiation (Clinical cure is defined as complete resolution of infection-related clinical signs & symptoms)Timepoint: From baseline till 10days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of patients achieving clinical improvement on Day 2, 3, 5, & 7 from treatment initiation (Clinical improvement is defined as partial resolution of infection-related clinical signs & symptoms) 2. Time to clinical improvement 3. Proportion of patients requiring addition of NSAID 4. Proportion of patients requiring addition/change in antibiotics 5. Proportion of patients with adverse eventsTimepoint: Day 2, 3, 5, 7 & 10 days | — |
Countries
India
Contacts
Public ContactDr Chintan Khandhedia
Sun Pharmaceutical Industries Limited
Outcome results
None listed